Deerfield Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Deerfield Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$541K	Buy
2024 Q1	–	Sell
2023 Q4	$305K	Buy
2015 Q2	–	Sell
2015 Q1	$1.61M	Buy
2013 Q3	–	Sell
2013 Q2	$19.4M	Buy